GGrantIndex
Sort

11,323 grants matching glioblastoma

Towards a quantitative understanding of tumor evolution

$972,000
Raul Rabadan · Columbia University Health Sciences · R35 · FY2025 · CA

Bioinformatic Tools in Cancer Research

$969,012
Kenneth Buetow · Division Of Basic Sciences - Nci · ZIH · FY2009 · CA

Tissue mechanics reprograms the tissue to malignancy and metastasis

$969,000
Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2020 · CA

Tissue mechanics reprograms the tissue to malignancy and metastasis

$969,000
Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2021 · CA

Immobilized Receptors In Drug Discovery

$968,328
Irving William Wainer · National Institute On Aging · ZIA · FY2012 · AG

Novel targeted Chemotherapeutics for Gliobastoma

$968,230
Kerry Jean Koller · Quadriga Biosciences, Inc. · R44 · FY2018 · CA

Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level

$967,866
Andrea Califano · Columbia University Health Sciences · U01 · FY2025 · CA

Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors

$964,830
Eric C Holland · Sloan-Kettering Inst Can Research · U54 · FY2011 · CA

Molecular, Cellular, and Tissue Characterization Unit

$964,136
William E Gillanders · Washington University · U2C · FY2019 · CA

Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance

$961,259
Jing Zhou · Isoplexis, Inc. · R44 · FY2020 · CA

RNA-binding Factors Implicated in Neurogenesis, Alzheimer's Disease, and other Neurodegenerative Pathologies

$961,086
Myriam Gorospe · National Institute On Aging · ZIA · FY2023 · AG

TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO

$961,000
Ajit S Shah · Omniox, Inc. · R44 · FY2013 · CA

Treatment of Glioblastoma: the combination of fluorescence guided surgery and photodynamic therapy

$960,821
William R Potter · Photolitec, Llc · R44 · FY2022 · CA

SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme

$960,270
Kevin Xu · Bexion Pharmaceuticals, Inc. · R44 · FY2013 · CA

The power of extracellular vesicles in glioblastoma

$959,035
Xandra Owens Breakefield · Massachusetts General Hospital · R35 · FY2024 · CA

Elucidating and Targeting tumor dependencies and drug resistance determinants at the single cell level

$956,166
Andrea Califano · Columbia University Health Sciences · U01 · FY2023 · CA

Tissue mechanics reprograms the tissue to malignancy and metastasis

$955,470
Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2025 · CA

Molecular Profiling of Patients Undergoing Radiotherapy

$954,589
Kevin Camphausen · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA

Targeting Glioblastoma Stem Cells

$954,000
Jeremy N Rich · University Of Pittsburgh At Pittsburgh · R35 · FY2024 · CA

Molecular Pathogenesis of Neoplasia

$953,971
John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS

Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma

$952,700
Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2020 · CA

Towards a quantitative understanding of tumor evolution

$952,560
Raul Rabadan · Columbia University Health Sciences · R35 · FY2022 · CA

Preclinical development of TIMP-2 as a biologic therapy for cancer

$951,648
William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma

$951,608
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Dynamic Complexity of Brain Tumor Stem Cells

$951,000
Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R35 · FY2015 · CA